연구성과로 돌아가기
2023 연구자 정보 (29 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Lee, Se Jin (Lee, SJ) |
Kangwon Natl Univ Hosp, Seongnam Si, Kyonggi Do, South Korea |
|
|
[JCR상위 1.1] Impacts of tocolytics on maternal and neonatal glucose levels in women with gestational diabetes mellitus | SCIE | 1.1 | OBSTETRICS & GYNECOLOGY | |||
|
Lee, Y-Y. (Lee, YY) |
Samsung Med Ctr SMC, Obstetr & Gynecol Dept, Seoul, South Korea |
|
|
[JCR상위 1.1] A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS/KOV-HIPEC-04) | SCIE | 1.1 | ONCOLOGY | |||
|
Li, W. (Li, W) |
First Hosp Jilin Univ, Tumor Ctr, Changchun, Jilin, Peoples R China MIT, Cambridge, MA USA Rice Univ, POB 1892, Houston, TX 77251 USA Ctr Frontiers Nucl Sci, Stony Brook, NY 11794 USA SUNY Stony Brook, 100 Nicolls Rd, Stony Brook, NY 11794 USA Coll William & Mary, Williamsburg, VA USA Rice Univ, Houston, TX USA Coll William & Mary, Williamsburg, VA 23185 USA |
HZJ-3346-2023 E-4702-2016 HSG-5924-2023 Li, Weiran Li, Bin xingyu, li |
0000-0002-8108-8045 Li, Wenliang |
[JCR상위 1.1] Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) [JCR상위 38.7] Detector requirements and simulation results for the EIC exclusive, diffractive and tagging physics program using the ECCE detector concept [JCR상위 38.7] Scientific computing plan for the ECCE detector at the Electron Ion Collider [JCR상위 38.7] Evaluation of longitudinal double-spin asymmetry measurements in semi-inclusive deep-inelastic scattering from the proton for the ECCE detector design [JCR상위 38.7] Exclusive J/ψ detection and physics with ECCE [JCR상위 38.7] Design and simulated performance of calorimetry systems for the ECCE detector at the electron ion collider [JCR상위 38.7] ECCE unpolarized TMD measurements [JCR상위 38.7] AI-assisted optimization of the ECCE tracking system at the Electron Ion Collider [JCR상위 38.7] ECCE sensitivity studies for single hadron transverse single spin asymmetry measurements [JCR상위 38.7] Search for e → ⠜ charged lepton flavor violation at the EIC with the ECCE detector [JCR상위 2.3] Precision studies of QCD in the low energy domain of the EIC |
SCIE | 1.1 |
ONCOLOGY INSTRUMENTS & INSTRUMENTATION;NUCLEAR SCIENCE & TECHNOLOGY;PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS PHYSICS, NUCLEAR;PHYSICS, PARTICLES & FIELDS |
billlee@jlab.org; josborn1@bnl.gov; cvanhuls@mail.cern.ch; xinbai@mail.ustc.edu.cn;first@ustc.edu.cn; fbock@cern.ch; rseidl@riken.jp; cfanelli@wm.edu; xiaochao@jlab.org; burkert@jlab.org; |
||
|
Li, Wei (Li, W) |
1st Hosp Jilin Univ, Changchun, Peoples R China |
|
|
[JCR상위 1.1] T-DXd vs TPC in patients with HER2-low unresectable and/or metastatic BC in Asian subgroup: Results of DESTINY-Breast04 | SCIE | 1.1 | ONCOLOGY | |||
|
Li, Y. (Li, Y) |
Hebei Med Univ North Gate, Gastroenterol Dept, Hosp 4, Shijiazhuang, Hebei, Peoples R China Beijing Forestry Univ, Sch Ecol & Nat Conservat, Inst Microbiol, Beijing 100083, Peoples R China |
|
|
[JCR상위 1.1] Bemarituzumab (bema)+FOLFOX6 as first-line treatment in patients with FGFR2b overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer (G/ GEJC): East Asia subgroup of FIGHT final analysis [JCR상위 7.6] Global consortium for the classification of fungi and fungus-like taxa |
SCIE | 1.1 |
ONCOLOGY MYCOLOGY |
cicidaidongqin@gmail.com;LQ@mail.qjnu.edu.cn; | ||
|
Lim, M. C. (Lim, MC) |
제1저자 | NCC Natl Canc Ctr, Gynecol Canc Ctr, Goyang Si, South Korea |
|
|
[JCR상위 1.1] A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS/KOV-HIPEC-04) | SCIE | 1.1 | ONCOLOGY | ||
|
Lu, Yen-Shen (Lu, YS) |
Natl Taiwan Univ Hosp, Taipei, Taiwan |
AAO-4015-2020 Shen, Yuchen |
|
[JCR상위 1.1] T-DXd vs TPC in patients with HER2-low unresectable and/or metastatic BC in Asian subgroup: Results of DESTINY-Breast04 | SCIE | 1.1 | ONCOLOGY | |||
|
Mabood, Fazal (Mabood, F) |
Univ Swat, Inst Chem Sci, Khyber Pakhtunkhwa 19130, Pakistan |
L-4868-2019 Mabood, Fazal |
|
[JCR상위 1.1] Exploration of metal organic frameworks and covalent organic frameworks for energy-related applications | SCIE | 1.1 | CHEMISTRY, INORGANIC & NUCLEAR | Jiabao.yi@newcastle.edu.au;liang.qiao@uestc.edu.cn; | ||
|
Malhotra, U. (Malhotra, U) |
Merck & Co Inc, MRL, Rahway, NJ USA |
|
|
[JCR상위 1.1] Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC): Updated efficacy and safety from KEYNOTE-966 | SCIE | 1.1 | ONCOLOGY | |||
|
Masci, G. (Masci, G) |
Humanitas Clin Res Hosp Rozzano, Med Oncol, Rozzano, MI, Italy |
|
|
[JCR상위 1.1] Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) | SCIE | 1.1 | ONCOLOGY | |||
|
Modi, S. (Modi, S) |
Mem Sloan Kettering Canc Ctr, Med, New York, NY USA |
|
|
[JCR상위 1.1] Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) | SCIE | 1.1 | ONCOLOGY | |||
|
Modi, Shanu (Modi, S) |
Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA |
|
|
[JCR상위 1.1] T-DXd vs TPC in patients with HER2-low unresectable and/or metastatic BC in Asian subgroup: Results of DESTINY-Breast04 [JCR상위 1.7] Trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) in patients (pts) with HER2-low, hormone receptor-positive (HR plus ) unresectable and/or metastatic breast cancer (mBC): Exploratory biomarker analysis of DESTINY-Breast04 |
SCIE | 1.1 | ONCOLOGY | |||
|
Mondol, Md Mahmudul Hassan (Mondol, MMH) |
AAM-8718-2021 Hassan Mondol, Md Mahmudul |
|
[JCR상위 1.1] MOFs with bridging or terminal hydroxo ligands: Applications in adsorption, catalysis, and functionalization | SCIE | 1.1 | CHEMISTRY, INORGANIC & NUCLEAR | sung@knu.ac.kr; | |||
|
Mondol, Md. Mahmudul Hassan (Mondol, MMH) |
제1저자 |
Kyungpook Natl Univ, Green Nano Mat Res Ctr, Dept Chem, Daegu 41566, South Korea Khulna Univ Engn & Technol KUET, Dept Chem Engn, Khulna 9203, Bangladesh Kyungpook Natl Univ, Dept Chem, Daegu, South Korea Kyungpook Natl Univ, Green Nano Mat Res Ctr, Daegu, South Korea Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea Kyungpook Natl Univ, Green Nano Mat Res Ctr, Daegu 41566, South Korea Bangladesh Council Sci & Ind Res, Rajshahi Labs, Rajshahi 6206, Bangladesh |
AAM-8718-2021 Hassan Mondol, Md Mahmudul |
|
[JCR상위 1.1] Metal-organic frameworks and metal-organic framework-derived materials for denitrogenation of liquid fuel via adsorption and catalysis [JCR상위 1.1] Preparation and applications of metal-organic frameworks composed of sulfonic acid [JCR상위 8.5] Zirconium oxide@N-doped porous carbons with oxygen vacancies, derived from zirconium chloride embedded metal-azolate framework-6: A new oxidative desulfurization catalyst [JCR상위 16.7] A comprehensive review of carbon nanotube-based metal oxide nanocomposites for supercapacitors |
SCIE | 1.1 |
CHEMISTRY, INORGANIC & NUCLEAR ENGINEERING, CHEMICAL ENERGY & FUELS |
sung@knu.ac.kr; abulkmallik@du.ac.bd; |
|
|
Moon, H. (Moon, H) |
Daegu Gyeongbuk Med Innovat Fdn, Daegu, South Korea |
|
|
[JCR상위 1.1] CHEMOKINE RECEPTOR CXCR7 CONTRIBUTE TO THE INFLAMMATORY REACTION OF ARTICULAR CHONDROCYTE | SCIE | 1.1 | ORTHOPEDICS;RHEUMATOLOGY |
페이지 이동: